Wordt geladen...
国产达沙替尼二线治疗慢性髓性白血病慢性期患者的疗效和安全性分析
OBJECTIVE: To investigate the efficiency and safety of domestic tyrosine kinase inhibitor (TKI) dasatinib (Yinishu) as second-line treatment for patients with chronic myeloid leukemia in chronic phase (CML-CP). METHODS: A retrospective analysis of clinical data of CML-CP patients who received domest...
Bewaard in:
| Gepubliceerd in: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Editorial office of Chinese Journal of Hematology
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342660/ https://ncbi.nlm.nih.gov/pubmed/30831623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.02.002 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|